NHPC, Tide Water Oil, Gujarat Themis Biosyn Among 6 Stocks to Trade Ex-Dividend Todayby Terry Bingman 9 months agoBiosyn, and more February 22, 2023 – Today, the stock market will see the trading focus shift to 6 notable ...
Virginia’s risky bet on ‘gray’ gamingby Mark Eisenberg 10 months ago“Click to share on Facebook” feature provides valuable insights into the popularity and reach of shared content. Website owners and ...
Google Workspace Streamlines Sharing for Better Collaborationby Lilu Anderson 10 months agoGoogle is streamlining document sharing with a new dropdown menu in popular apps like Docs, Sheets, and Slides, enhancing user ...
Abby Sherlock ’19: Disrupting Gaming, Defying Stereotypesby Lilu Anderson 10 months agoDiscover a collection of recommended books, films, music, and events to celebrate Asian American, Native Hawaiian, and Pacific Islander Heritage ...
NYC Debuts App to Track School Buses for Worried Familiesby Lilu Anderson 10 months agomessage, which creates a sense of personal connection and encourages interaction from their network. This interaction can come in the ...
“Haidian: Beijing’s Tech and Culture Hub”by Lilu Anderson 10 months agoDiscover how ride-sharing apps are revolutionizing urban transportation, reducing traffic congestion, and providing convenient and cost-effective options.
OneVerse’s Acquisition Strategy to Combat GST Pressureby John Darbie 10 months agoDiscover the power of sharing in the digital age. Learn how it can connect you with others, spread important messages, ...
Tenaris Completes $300M Share Buyback Trancheby Mark Eisenberg 10 months agoTenaris completes first phase of share buyback program, acquiring 17.8 million shares worth $300 million, aiming to enhance shareholder value.
Understanding Stock Splits: Effects on Share Prices and Investmentsby Mark Eisenberg 1 year agoStock splits are a common occurrence in the world of investing. They are a way for companies to increase the ...
Accent Therapeutics secures J&J and BMS as new investors in $75M series Cby Mark Eisenberg 10 months agoPharmaceutical giants Bristol Myers Squibb and Johnson & Johnson invest in Accent Therapeutics, a leading RNA drug developer, contributing to ...